
[ Thu, Jan 25th 2024 ]: WOPRAI
[ Thu, Jan 25th 2024 ]: WOPRAI
[ Thu, Jan 25th 2024 ]: WOPRAI
[ Thu, Jan 25th 2024 ]: WOPRAI
[ Thu, Jan 25th 2024 ]: WOPRAI
[ Thu, Jan 25th 2024 ]: WOPRAI
[ Thu, Jan 25th 2024 ]: WOPRAI
[ Thu, Jan 25th 2024 ]: WOPRAI
[ Thu, Jan 25th 2024 ]: WOPRAI
[ Thu, Jan 25th 2024 ]: WOPRAI
[ Thu, Jan 25th 2024 ]: WOPRAI
[ Thu, Jan 25th 2024 ]: WOPRAI
[ Thu, Jan 25th 2024 ]: WOPRAI
[ Thu, Jan 25th 2024 ]: WOPRAI
[ Thu, Jan 25th 2024 ]: WOPRAI
[ Thu, Jan 25th 2024 ]: WOPRAI
[ Thu, Jan 25th 2024 ]: WOPRAI
[ Thu, Jan 25th 2024 ]: WOPRAI
[ Thu, Jan 25th 2024 ]: WOPRAI
[ Thu, Jan 25th 2024 ]: WOPRAI
[ Thu, Jan 25th 2024 ]: WOPRAI
[ Thu, Jan 25th 2024 ]: WOPRAI
[ Thu, Jan 25th 2024 ]: WOPRAI
[ Thu, Jan 25th 2024 ]: WOPRAI
[ Thu, Jan 25th 2024 ]: WOPRAI
[ Thu, Jan 25th 2024 ]: WOPRAI
[ Thu, Jan 25th 2024 ]: WOPRAI
[ Thu, Jan 25th 2024 ]: WOPRAI
[ Thu, Jan 25th 2024 ]: WOPRAI
[ Thu, Jan 25th 2024 ]: WOPRAI
[ Thu, Jan 25th 2024 ]: WOPRAI
[ Thu, Jan 25th 2024 ]: WOPRAI
[ Thu, Jan 25th 2024 ]: WOPRAI
[ Thu, Jan 25th 2024 ]: WOPRAI
[ Thu, Jan 25th 2024 ]: WOPRAI
[ Thu, Jan 25th 2024 ]: WOPRAI
[ Thu, Jan 25th 2024 ]: WOPRAI
[ Thu, Jan 25th 2024 ]: WOPRAI
[ Thu, Jan 25th 2024 ]: WOPRAI
[ Thu, Jan 25th 2024 ]: WOPRAI
[ Thu, Jan 25th 2024 ]: WOPRAI
[ Thu, Jan 25th 2024 ]: WOPRAI
[ Thu, Jan 25th 2024 ]: WOPRAI
[ Thu, Jan 25th 2024 ]: WOPRAI
[ Thu, Jan 25th 2024 ]: WOPRAI
[ Thu, Jan 25th 2024 ]: WOPRAI
[ Thu, Jan 25th 2024 ]: WOPRAI
[ Thu, Jan 25th 2024 ]: WOPRAI
Jayson Bedford Maintained (ABT) at Buy with Increased Target to $127 on, Jan 25th, 2024


🞛 This publication is a summary or evaluation of another publication
Jayson Bedford of Raymond James, Maintained "Abbott Laboratories" (ABT) at Buy with Increased Target from $124 to $127 on, Jan 25th, 2024.
Jayson has made no other calls on ABT in the last 4 months.
There are 3 other peers that have a rating on ABT. Out of the 3 peers that are also analyzing ABT, 1 agrees with Jayson's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- David Lewis of "Morgan Stanley" Maintained at Hold with Decreased Target to $107 on, Thursday, October 19th, 2023
These are the ratings of the 2 analyists that currently disagree with Jayson
- Lawrence Biegelsen of "Wells Fargo" Maintained at Buy with Increased Target to $121 on, Wednesday, December 13th, 2023
- Matt Miksic of "Barclays" Maintained at Buy with Increased Target to $133 on, Thursday, October 19th, 2023